16 results on '"JOUENNE, Fanelie"'
Search Results
2. The key role of oncopharmacology in therapeutic management, from common to rare cancers: A literature review
3. Erratum to ‘Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin’ [EJC Skin Cancer 1 (2023) 100002]
4. Dramatic Response After Switching MEK Inhibitors in a Patient With Refractory Mixed Histiocytosis
5. Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin
6. Chapitre 8 - Traitements médicamenteux du cancer
7. The MAPK Pathway in Pulmonary Langerhans Cell Histiocytosis
8. Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance
9. CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
10. Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care
11. Phase I-II open label multicenter study of PD0332991 in BRAFV600mut metastatic melanoma patients harboring CDKN2A loss and RB1 expression and treated with vemurafenib.
12. A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors
13. Carcinomes épidermoïdes éruptifs dans un contexte de dermatose inflammatoire aiguë : une série de 4 cas
14. Conservative management is effective in unicystic ameloblastoma occurring from the neonatal period: A case report and a literature review
15. A Novel Case of Gorlin Syndrome Mosaicism Involving an SMO Gene Mutation: Clinical, Histological and Molecular Analysis of Basaloid Tumours.
16. Response to Trametinib of a Pulmonary Langerhans Cell Histiocytosis Harboring a MAP2K1 Deletion.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.